The company says the early trial of its androgenic alopecia therapy saw patients benefit from six times more hair growth than ...

BAE Systems’ subsidiary Bohemia Interactive Simulations (BISim) has initiated a strategic partnership with Rheinmetall to ...

Bakery major Flowers Foods is adding to its presence in snacks with the acquisition of US biscuit and snack-bar maker Simple Mills for $795m.

Licensing deals have risen in prominence in a restrained market environment. Is it desperation, or an important part of the ...

ISM5411 was well tolerated and demonstrated a favourable pharmokinetic profile in validating gut-restrictive properties.

With clinical trials facing multiple challenges, digital solutions could provide the answer. We identify the key trends to watch in 2025.

One year after the EU mandated separate collection of bio-waste, a significant portion of Europe's organic waste still ends up in landfills and incinerators.

Acelyrin plans to initiate two Phase III studies this quarter, which will enrol up to 350 patients with thyroid eye disease (TED).

GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

OSI Systems has announced a $27m order for its security division to provide checkpoint and baggage solutions to ainternational customer.

Data from the largest US Lyme disease registry suggests that 90% of PLD patients are excluded from clinical trials.

Novartis has announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) achieved the primary ...